Eisai, Biogen (BIIB) Alzheimer drug granted FDA accelerated approval
Go back to Eisai, Biogen (BIIB) Alzheimer drug granted FDA accelerated approval| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 216.73 +2.38 (1.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $214.35 | 52 Week High | $333.65 | |||
| Open | $217.76 | 52 Week Low | $223.02 | |||
| Day High | $219.12 | P/E | 27.75 | |||
| Day Low | $215.00 | EPS | $7.81 | |||
| Volume | 414,482 | |||||

